LANCE™: Homogeneous Assay Platform for HTS

Hemmila, I. (1991). Applications of Fluorescence in Immunoassays. Wiley Interscience, New York.

Soini, E. , Hemmild, I. (1979). Fluoroimmunoassays: Present status and key problems. Clin. Chem. 25:353-361.

Meurman, O.H. , Hemmil, I. , Ltvgren, T. , Halonen, P. (1982). Time-resolved fluoroimmunoassay: A new test for Rubella antibodies. J. Clin. Microbiol. 16:920-925.

Siitari, H. , Hemmila, I. , Soini, E. , LUvgren, T. , Koistinen, V. (1983). Detection of Hepatitis B surface antigen using time-resolved fluoroimmunoassay. Nature 301:258-260.

Hemmila, I. , Dakubu, S. , Mukkala, V.-M. , Siitari, H. , Lovgren, T. (1984). Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137:335-343.

Mathis, G. (1993). Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin. Chem. 39:1953-1959.

Kolb, A. , Burke, J.W. , Mathis, G. (1997). Homogeneous, time-resolved fluorescence method for drug discovery. In High Throughput Screening: The Discovery of Bioactive Substances. J.P. Devlin (ed), pp. 345-360. Marcel Dekker Inc., New York.

Blomberg, K. , Granberg, C. , Hemmila, I. , Lovgren, T. (1986). Europium labelled target cells in assay of NK-activity. I A novel nonradioactive method based on time resolved fluorescence. J. Immunol. Methods 86:225-229.

Blomberg, K. , Ulfstedt, A.C. (1993). Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J. Immunol. Methods 160:27-34.

Blomberg, K. , Hautala, R. , Ldvgren, J. , Mukkala, V.-M. , Lindqvist, C. , Akerman, K. (1996). Time-resolved fluorometric assay for natural killer cell activity using target cells labelled with a fluorescence enhancing ligand. J. Immunol. Methods 193:199-206.

Hemmili, I. , Malminen, O. , Mikola, H. , Ltvgren, T. (1988). Homogeneous time-resolved fluoroimmunoassay of thyroxin in serum. Clin. Chem. 34:2320-2322.

Hemmili, I. (1997). Optimized chelate-labels for homogeneous and heterogeneous screening assays. In High Throughput Screening. Novel Assay Design, Rapid Target Development and Accelerated Level Optimization. W. Hori and L.M. Savage (eds), pp. 211-236,. IBC Library Series, Southborough, MA.

Morrison, L.E. (1988). Time-resolved detection of energy transfer: Theory and application to immunoassays. Anal. Biochem. 174:101-120.

Moore, K.J. , Turconi, S. , Miles-Williams, A. , Djaballah, H. , Hurskainen, P. , Harrop, J. , Murray, K.J. , Pope, A.J. (1999). J. Biomol. Screen 4:205-214.

Selvin, P. (1995). Fluorescence resonance energy transfer. Methods in Enzymol. 246:300-334.

Park, Y.-W. (1999). Critical evaluation of homogeneous proximity assays. High Throughput Screening, IBC's 8th Ann. Int. Conf Berkeley, CA, March 1-3.

He, Y. (1997). Assay development for high-throughput screening: Practical considerations in drug discovery. In High Throughput Screening. Novel Assay Design, Rapid Target Development and Accelerated Level Optimization. W. Hori and L.M. Savage (eds), pp. 115-128, IBC Library Series, Southborough, MA.

Leif, R.C. , Thomas, R.A. , Yopp, T.A. , Watson, B.D. , Guarino, V.R. , Hindman, D.H.K. , Lefkove, N. , Vallarino, L.M. (1977). Clin. Chem. 23:1492-1498.

Wieder, I. (1978). Background rejection in fluorescence immunoassay. In Immunofluorescence and Related Staining Techniques. Proc. VIth International Conference on Immunofluorescence and Related Staining Techniques, W. Knapp , K. Holubar , and G. Wick (eds.) Elsevier/North Holland Biomedical Press, Amsterdam, pp. 67-80.

Diamandis, E.P. (1988). Immunoassays with time-resolved fluorescence spectroscopy. Principles and applications [Review]. Clin. Chem. 21:139-150.

Hemmila, I. , Webb, S. (1997). Time resolved fluorometry: an overview of the labels and core technologies for drug screening applications. Drug Discovery Today 2:373-381.